Brief: 1nkemia announces positive results in R&D on muscular dystrophy
June 30 (Reuters) - 1nkemia IUCT Group SA IKM.MC :
* Says positive results on research and development project
with 6 compounds of the rare disease: hypotonic muscular
dystrophy
* Says results have been protected with the presentation of
two international patents
* 1nkemia's unit IUCT SA has 38 pct in consortium
responsible for this project
Source text: http://bit.ly/1GKdvpp
Further company coverage: IKM.MC
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on 1nkemia IUCT SA
See all newsBrief: 1nKemia Proceeds To Divest Its Stake In Leanbio For 0.3 Mln Euros
Brief: 1nKemia Says Crescent Hill Signs LOI To Buy Significant Stake In Company
Brief: 1nKemia Unit Files For Insolvency Proceedings
Brief: InKemia Files For Pre-Insolvency Proceedings
Brief: 1nkemia Closes Bond Issue, Positively Evaluates 3.6 Mln Euro Investment